Autolus Therapeutics plc held its 2025 Annual General Meeting of Shareholders on June 26, 2025. During the meeting, several proposals were considered and approved. These included the adoption of the company's financial accounts for the year ended December 31, 2024, and the re-appointment of Ernst & Young LLP as auditors. Additionally, the re-election of Dr. R Rao and Dr. R Iannone as directors was approved. The Autolus Therapeutics plc Employee Share Purchase Plan with Sharesave Sub-Plan was also approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autolus Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001730463-25-000046), on June 27, 2025, and is solely responsible for the information contained therein.